Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060040/S128

HeartMate II LVAS

ABBOTT MEDICAL · Decision date Oct 1, 2026

MEDTECHLEDGER EXPLANATIONP060040/S128

What did the FDA decide?

The FDA record for P060040/S128, dated 2026-10-01 with decision code OK30, is a 30-Day Notice supplement to the HeartMate II LVAS premarket approval, filed by Abbott Medical under product code DSQ for ventricular assist bypass devices. The stated change is the addition of new top case critical dimensions to be measured, together with a new measurement gauge. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager, or supplier categories.

The record ties this supplement to the original P060040 approval through its identifier, but a supplement is not a new approval of the whole system, and a manufacturing notice is not an original PMA. The statement's purpose covers added inspection measurement only; it does not address clinical safety, effectiveness, or performance of the device itself. What the specific dimensions are, which gauge is used, and how conformity is verified are not described in the supplied fields.

FDA approval order statement

addition of new top case critical dimensions to be measured and a new measurement gauge
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 1, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P060040/S128
Regulatory pathway
PMA supplement
Product code
DSQ
Decision code
OK30
Decision date
Oct 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P060040. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P060040 · Original PMA

    THORATEC HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM

  2. P060040/S128 received

    Application receipt date recorded by FDA.

  3. P060040/S128 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P060040. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060040

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalApr 21, 2008FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
AbbottPMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records